{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:32:30Z","timestamp":1786789950556,"version":"build-2736575974"},"reference-count":38,"publisher":"Baishideng Publishing Group Inc.","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.3360","type":"journal-article","created":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T06:21:22Z","timestamp":1213338082000},"page":"3360","source":"Crossref","is-referenced-by-count":83,"title":["Autoimmune paediatric liver disease"],"prefix":"10.3748","volume":"14","author":[{"given":"Giorgina","family":"Mieli-Vergani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, Mowat AP, Vergani D, Mieli-Vergani G. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-547.","DOI":"10.1002\/hep.510250308"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829-1836.","DOI":"10.1056\/NEJM199006283222601"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.","DOI":"10.1002\/hep.1840180435"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938.","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Vergani D, Alvarez F, Bianchi FB, Cançado EL, Mackay IR, Manns MP, Nishioka M, Penner E. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004;41:677-683.","DOI":"10.1016\/j.jhep.2004.08.002"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG. Range of antinuclear antibodies in \"healthy\" individuals. Arthritis Rheum 1997;40:1601-1611.","DOI":"10.1002\/art.1780400909"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 1976;29:403-410.","DOI":"10.1136\/jcp.29.5.403"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Muratori P, Muratori L, Agostinelli D, Pappas G, Veronesi L, Granito A, Cassani F, Terlizzi P, Lenzi M, Bianchi FB. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity 2002;35:497-500.","DOI":"10.1080\/0891693021000054066"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Gregorio GV, Portmann B, Mowat AP, Vergani D, Mieli-Vergani G. A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis. J Hepatol 1997;27:751-754.","DOI":"10.1016\/S0168-8278(97)80093-1"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Dahlan Y, Smith L, Simmonds D, Jewell LD, Wanless I, Heathcote EJ, Bain VG. Pediatric-onset primary biliary cirrhosis. Gastroenterology 2003;125:1476-1479.","DOI":"10.1016\/j.gastro.2003.08.022"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Donaldson PT. Genetics in autoimmune hepatitis. Semin Liver Dis 2002;22:353-364.","DOI":"10.1055\/s-2002-35705"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Lapierre P, Hajoui O, Homberg JC, Alvarez F. Formimino-transferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 1999;116:643-649.","DOI":"10.1016\/S0016-5085(99)70186-1"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;1:292-294.","DOI":"10.1016\/S0140-6736(87)92024-1"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, Underhill J, Dürr R, Mieli-Vergani G, Vergani D. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002;35:658-664.","DOI":"10.1053\/jhep.2002.32092"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006;130:868-882.","DOI":"10.1053\/j.gastro.2005.12.020"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Fainboim L, Canero Velasco MC, Marcos CY, Ciocca M, Roy A, Theiler G, Capucchio M, Nuncifora S, Sala L, Zelazko M. Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis. Hepatology 2001;33:1512-1517.","DOI":"10.1053\/jhep.2001.24562"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Pando M, Larriba J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, Badia I, Daruich J, Findor J, Tanno H. Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 1999;30:1374-1380.","DOI":"10.1002\/hep.510300611"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Vergani D, Wells L, Larcher VF, Nasaruddin BA, Davies ET, Mieli-Vergani G, Mowat AP. Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis. Lancet 1985;2:294-298.","DOI":"10.1016\/S0140-6736(85)90348-4"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Lévy VG, Grippon P. Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \"autoimmune\" hepatitis. Hepatology 1987;7:1333-1339.","DOI":"10.1002\/hep.1840070626"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G. Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33:544-553.","DOI":"10.1053\/jhep.2001.22131"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, Vergani D. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. Hepatology 1996;24:520-523.","DOI":"10.1002\/hep.510240309"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998;112:471-476.","DOI":"10.1046\/j.1365-2249.1998.00574.x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 2005;11:441-448.","DOI":"10.1002\/lt.20352"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Liston A, Lesage S, Gray DH, Boyd RL, Goodnow CC. Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol Rev 2005;204:87-101.","DOI":"10.1111\/j.0105-2896.2005.00253.x"},{"key":"ref25","unstructured":"Simmonds MJ, Gough SC. Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 2004;71:93-113."},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Mieli-Vergani G, Vergani D. Autoimmune hepatitis in children. Clin Liver Dis 2002;6:623-634.","DOI":"10.1016\/S1089-3261(02)00020-X"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Rumbo C, Emerick KM, Emre S, Shneider BL. Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report. J Pediatr Gastroenterol Nutr 2002;35:391-398.","DOI":"10.1097\/00005176-200209000-00032"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kerkar N, Annunziato RA, Foley L, Schmeidler J, Rumbo C, Emre S, Shneider B, Shemesh E. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr 2006;43:629-634.","DOI":"10.1097\/01.mpg.0000239735.87111.ba"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Heneghan MA, Norris SM, O'Grady JG, Harrison PM, McFarlane IG. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001;48:97-102.","DOI":"10.1136\/gut.48.1.97"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Gregorio GV, McFarlane B, Bracken P, Vergani D, Mieli-Vergani G. Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease. Autoimmunity 2002;35:515-519.","DOI":"10.1080\/0891693021000056721"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Mieli-Vergani G, Bargiota K, Samyn M, Vergani D. Therapeutic aspects of autoimmune liver disease in children. Autoimmune Liver Diseases-Falk Symposium Dordrecht: Springer; 2005;278-282.","DOI":"10.1007\/1-4020-2914-4_25"},{"key":"ref32","unstructured":"Samaroo B, Samyn M, Buchanan C, Mieli-Vergani G. Long-term daily oral treatment with prednisolone in children with autoimmune liver disease does not affect final adult height. Hepatology 2006;44:438A."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995;333:958-963.","DOI":"10.1056\/NEJM199510123331502"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Abdalian R, Dhar P, Jhaveri K, Haider M, Guindi M, Heathcote EJ. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology 2008;47:949-957.","DOI":"10.1002\/hep.22073"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Bucy PB, Yan Xu X, Li J, Huang GQ. Cyclosporin A-induced autoimmune disease in mice. J Immunol 1993;151:1039-1050.","DOI":"10.4049\/jimmunol.151.2.1039"},{"key":"ref36","unstructured":"Cooper MH, Hartman GG, Starzl TE, Fung JJ. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc 1991;23:3234-3235."},{"key":"ref37","unstructured":"Hess AD, Fischer AC, Horwitz LR, Laulis MK. Cyclosporine-induced autoimmunity: critical role of autoregulation in the prevention of major histocompatibility class II-dependent autoaggression. Transplant Proc 1993;25:2811-2813."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991;13:701-706.","DOI":"10.1002\/hep.1840130415"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i21\/3360.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:10:21Z","timestamp":1684440621000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i21\/3360.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":38,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.3360","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}